Detection of prostate cancer with (18)F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial

PURPOSE: In primary prostate cancer (PCa) patients, accurate staging and histologic grading are crucial to guide treatment decisions. (18)F-DCFPyL (PSMA)-PET/CT has been successfully introduced for (re)staging PCa, showing high accuracy to localise PCa in lymph nodes and/or osseous structures. The d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodar, Y. J. L., Jansen, B. H. E., van der Voorn, J. P., Zwezerijnen, G. J. C., Meijer, D., Nieuwenhuijzen, J. A., Boellaard, R., Hendrikse, N. H., Hoekstra, O. S., van Moorselaar, R. J. A., Oprea-Lager, D. E., Vis, A. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332599/
https://www.ncbi.nlm.nih.gov/pubmed/33079250
http://dx.doi.org/10.1007/s00345-020-03490-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332599/
https://www.ncbi.nlm.nih.gov/pubmed/33079250
http://dx.doi.org/10.1007/s00345-020-03490-8

Ejemplares similares